COMPANY
Sequentify develops genomic samples processing products and technologies, prior to sequencing hardware loading
Company Management
Advisory Board
Board of Directors
Mission statement
At Sequentify, our mission is to eliminate the barriers that hinder the widespread adoption of NGS as a routine, population-wide solution. This applies not only to healthcare but also extends to agri-tech, animal science, research, and beyond. To achieve this, scalability must permeate every aspect of the NGS workflow.
While the cost of sequencing per base continues to decline due to advancements in sequencing platforms, innovation from sequencing companies has shifted the bottleneck of the workflow upstream to the library preparation stage.
Our objective is to facilitate the decentralization of NGS, empowering laboratories of all sizes to efficiently sequence samples at scale, whether through manual processes, entry-level automation, or high-end liquid handlers.
We aspire to elevate every laboratory into a high-throughput facility.
Quality accreditation
Sequentify proudly possesses ISO 13485 accreditation for manufacturing Next-Generation Sequencing kits. With a strong commitment to quality and precision, Sequentify offers reliable solutions that empower researchers and healthcare professionals in genomics research.
Press releases
Democratizing Genomics, Sequentify Raises $7M to Enable DNA Sequencing at Scale
Democratizing Genomics, Sequentify Raises $7M to Enable DNA Sequencing at Scale
Democratizing Genomics, Sequentify Raises $7M to Enable DNA Sequencing at Scale
Sequentify Ltd.
10 Moti Kind, St, 5th Floor, Rehovot, Israel 7638519